SIDI A. BENCHERIF

Prof. SIDI A. BENCHERIF

Chemical Engineering, Northeastern University, Boston, MA, USA
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2015 in Nature Materials
Verified
Journal Article
Open access
PDF file
OCOvijit Chaudhuri
Ovijit Chaudhuri
LGLuo Gu
Luo Gu
DKDarinka Klumpers
Darinka Klumpers
MDMax Darnell
Max Darnell
SIDI A. BENCHERIFSIDI A. BENCHERIF
SIDI A. BENCHERIF
DMDavid J. Mooney
David J. Mooney
Natural extracellular matrices (ECMs) are viscoelastic and exhibit stress relaxation. However, hydrogels used as synthetic ECMs for three-dimensional (3D) culture are typically elastic. Here, we report a materials approach to tune the rate of stress relaxation of hydrogels for 3D culture, independently of the hydrogel’s initial elastic modulus, degradation, and cell-adhesion-ligand density. We find that cell spreading, proliferation, and osteogenic differentiation of mesenchymal stem cells (MSCs) are all enhanced in cells cultured in gels with faster relaxation. Strikingly, MSCs form a mineralized, collagen-1-rich matrix similar to bone in rapidly relaxing hydrogels with an initial elastic modulus of 17 kPa. We also show that the effects of stress relaxation are mediated by adhesion-ligand binding, actomyosin contractility and mechanical clustering of adhesion ligands. Our findings highlight stress relaxation as a key characteristic of cell–ECM interactions and as an important design parameter of biomaterials for cell culture.

25 April 2010 in Nature Materials
Verified
Journal Article
Open access
PDF file
NHNathaniel Huebsch
Nathaniel Huebsch
PAPraveen Arany
Praveen Arany
AMAngelo S. Mao
Angelo S. Mao
DSDmitry Shvartsman
Dmitry Shvartsman
OAOmar A. Ali
Omar A. Ali
DMDavid J. Mooney
David J. Mooney
Stem cells sense and respond to the mechanical properties of the extracellular matrix. However, both the extent to which extracellular-matrix mechanics affect stem-cell fate in three-dimensional microenvironments and the underlying biophysical mechanisms are unclear. We demonstrate that the commitment of mesenchymal stem-cell populations changes in response to the rigidity of three-dimensional microenvironments, with osteogenesis occurring predominantly at 11–30 kPa. In contrast to previous two-dimensional work, however, cell fate was not correlated with morphology. Instead, matrix stiffness regulated integrin binding as well as reorganization of adhesion ligands on the nanoscale, both of which were traction dependent and correlated with osteogenic commitment of mesenchymal stem-cell populations. These findings suggest that cells interpret changes in the physical properties of adhesion substrates as changes in adhesion-ligand presentation, and that cells themselves can be harnessed as tools to mechanically process materials into structures that feed back to manipulate their fate.

19 February 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
OCOvijit Chaudhuri
Ovijit Chaudhuri
LGLuo Gu
Luo Gu
MDMax Darnell
Max Darnell
DKDarinka Klumpers
Darinka Klumpers
SIDI A. BENCHERIFSIDI A. BENCHERIF
SIDI A. BENCHERIF
DMDavid J. Mooney
David J. Mooney
Studies of cellular mechanotransduction have converged upon the idea that cells sense extracellular matrix (ECM) elasticity by gauging resistance to the traction forces they exert on the ECM. However, these studies typically utilize purely elastic materials as substrates, whereas physiological ECMs are viscoelastic, and exhibit stress relaxation, so that cellular traction forces exerted by cells remodel the ECM. Here we investigate the influence of ECM stress relaxation on cell behaviour through computational modelling and cellular experiments. Surprisingly, both our computational model and experiments find that spreading for cells cultured on soft substrates that exhibit stress relaxation is greater than cells spreading on elastic substrates of the same modulus, but similar to that of cells spreading on stiffer elastic substrates. These findings challenge the current view of how cells sense and respond to the ECM.

10 August 2012 in Science
Verified
Journal Article
Closed access
PDF file
NKNetanel Korin
Netanel Korin
MKMathumai Kanapathipillai
Mathumai Kanapathipillai
BMBenjamin D. Matthews
Benjamin D. Matthews
MCMarilena Crescente
Marilena Crescente
Alexander BrillAlexander Brill
Alexander Brill
DIDonald E Ingber
Donald E Ingber
Bio-Inspired Drug Delivery: Noting that platelets naturally migrate to narrowed blood vessels characterized by high fluid shear stress, Korin et al. (p. 738 , published online 5 July; see the Perspective by Lavik and Ustin ) developed a nanoparticle-based therapeutic that uses a similar targeting mechanism to deliver a drug to vessels obstructed by blood clots. Aggregates of nanoparticles coated with the clot-dissolving drug tPA (tissue plasminogen activator) were designed to fall apart and release the drug only when encountering high fluid shear stress. In preclinical models, the bio-inspired therapeutic dissolved clots and restored normal blood flow at lower doses than free tPA, suggesting that this localized delivery system may help reduce the risk of side effects such as excessive bleeding.

12 November 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SIDI A. BENCHERIFSIDI A. BENCHERIF
SIDI A. BENCHERIF
RSR. Warren Sands
R. Warren Sands
DBDeen Bhatta
Deen Bhatta
PAPraveen Arany
Praveen Arany
CVCatia S. Verbeke
Catia S. Verbeke
DMDavid J. Mooney
David J. Mooney
Injectable biomaterials are increasingly being explored to minimize risks and complications associated with surgical implantation. We describe a strategy for delivery via conventional needle–syringe injection of large preformed macroporous scaffolds with well-defined properties. Injectable 3D scaffolds, in the form of elastic sponge-like matrices, were prepared by environmentally friendly cryotropic gelation of a naturally sourced polymer. Cryogels with shape-memory properties may be molded to a variety of shapes and sizes, and may be optionally loaded with therapeutic agents or cells. These scaffolds have the capability to withstand reversible deformations at over 90% strain level, and a rapid volumetric recovery allows the structurally defined scaffolds to be injected through a small-bore needle with nearly complete geometric restoration once delivered. These gels demonstrated long-term release of biomolecules in vivo. Furthermore, cryogels impregnated with bioluminescent reporter cells provided enhanced survival, higher local retention, and extended engraftment of transplanted cells at the injection site compared with a standard injection technique. These injectable scaffolds show great promise for various biomedical applications, including cell therapies.

12 August 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
SIDI A. BENCHERIFSIDI A. BENCHERIF
SIDI A. BENCHERIF
RSR. Warren Sands
R. Warren Sands
OAOmar A. Ali
Omar A. Ali
WLWeiwei A. Li
Weiwei A. Li
SLSarah A. Lewin
Sarah A. Lewin
DMDavid J. Mooney
David J. Mooney
A biomaterial-based vaccination system that uses minimal extracorporeal manipulation could provide in situ enhancement of dendritic cell (DC) numbers, a physical space where DCs interface with transplanted tumour cells, and an immunogenic context. Here we encapsulate GM-CSF, serving as a DC enhancement factor, and CpG ODN, serving as a DC activating factor, into sponge-like macroporous cryogels. These cryogels are injected subcutaneously into mice to localize transplanted tumour cells and deliver immunomodulatory factors in a controlled spatio-temporal manner. These vaccines elicit local infiltrates composed of conventional and plasmacytoid DCs, with the subsequent induction of potent, durable and specific anti-tumour T-cell responses in a melanoma model. These cryogels can be delivered in a minimally invasive manner, bypass the need for genetic modification of transplanted cancer cells and provide sustained release of immunomodulators. Altogether, these findings indicate the potential for cryogels to serve as a platform for cancer cell vaccinations.